A combination of immunotherapy and targeted cancer treatment given before and after surgery may reduce the risk of recurrence and improve survival in ...

Conditional approval of intravesical gene therapy was supported by clinical evidence showing a 53.4% complete response rate in patients with treatment-resistant non-muscle-invasive bladder cancer.

When contextualized with the developments across all genitourinary [GU] malignancies, especially renal cell carcinoma and ...

A vaccine that is injected directly into tumours could boost survival rates from hard-to-treat cancers. The one-off jab works ...

This week in oncology, the FDA expanded the treatment landscape for platinum-resistant ovarian cancer with a new approval, and significant clinical data emerged regarding novel in ...

As cancer care becomes both more advanced and more specialized, options in rural areas have shrunk.

Non–muscle-invasive bladder cancer (NMIBC) and muscle-invasive bladder cancer (MIBC) continue to pose significant clinical and health-economic challenges in ...

WASHINGTON (AP) — Federal health officials issued a warning Tuesday over misleading statements made by biotech billionaire Dr. Patrick Soon-Shiong, who recently told podcast listeners that his company ...

Chronic stress worsens cancer by activating the neuroendocrine system, releasing cortisol and adrenaline that weaken immunity and promote tumor growth and spread.

The founder said that 50% of enrolled patients in the Phase 3 bladder cancer study reached an evaluable efficacy endpoint, ...

After collecting an FDA approval earlier this year for local pancreatic cancer, Novocure is putting forward positive clinical ...

In breast cancer patients, radiotherapy may reduce lymphedema (arm swelling) risk compared to surgery after neoadjuvant therapy, offering a less invasive option.